Related Experiment Video
Updated: Apr 16, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
[Risk factors of contrast-induced nephropathy in patients with myocardial infarction]
Insights
Contrast-induced nephropathy (CIN) affects 7.2% of ST-segment elevation myocardial infarction patients, with diabetes mellitus and acute cardiac failure as key predictors. CIN significantly increases adverse cardiovascular events and hospital prognosis risks.
Area of Science:
- Cardiology
- Nephrology
- Radiology
Context:
- Contrast-induced nephropathy (CIN) is a significant concern in patients undergoing procedures with contrast agents.
- ST-segment elevation myocardial infarction (STEMI) patients often require contrast-enhanced imaging, increasing their risk for CIN.
- Understanding CIN predictors is crucial for risk stratification and patient management in acute cardiac events.
Purpose:
- To identify predictors of contrast-induced nephropathy (CIN).
- To evaluate the impact of CIN on the hospital prognosis of ST-segment elevation myocardial infarction (STEMI).
Summary:
- CIN was diagnosed in 7.2% of STEMI patients.
- Independent predictors of CIN included a history of diabetes mellitus (DM) and acute cardiac failure (ACF) (Killip class II-IV).
- CIN was associated with reduced left ventricular ejection fraction (LVEF) and increased risks of adverse cardiovascular events.
Impact:
- Identifies high-risk patient groups for CIN in STEMI.
- Highlights the prognostic significance of CIN in STEMI patients.
- Informs clinical decision-making for contrast agent administration and preventative strategies.
Aim:
To identify predictors of contrast-induced nephropathy (CIN) and evaluate its significance for the hospital prognosis of myocardial infarction with elevated ST segment.
Materials And Methods:
722 (75.7%) of the total 954 patients underwent X ray examination with the use of contrast material (coronary angiography (CAG) and/or transcutaneous coronary intervention (TCI)) within 24 hr after the appearance of symptoms. In all cases, serum creatinine level was determined and glomerular filtration rate (GFR) calculated by the MDRD formula at admission, 2-3 days after CAG/TCI, and 10-14 days after hospitalization. CIN was defined as a more than 25% (44 mcmnol/l) rise in the creatinine level compared with the initial one within 48-72 hr after intravascular administration of contrast material in the absence of an alternative cause. The endpoints (adverse cardiovascular effects) were evaluated at the hospital stage of the study.
Results:
Significantly more patients with CIN (n=52; 7.2%) had the history ofdiabetes mellitus (DM) and chronic renal disease (CRD), clinically manifest Killip class II-IV acute cardiac failure (ACF), and reduced left ventricular ejection fraction (LVEF) compared with the patients having normal renal function. The risk of RAEF in the presence of CIN increased by 2.5 times (95% CI 1.26-5.05), that of MI by 5.4% (95% CI 2.69-10.64), life-threatening and other complications by 4.1% (95% CI 1.99-8.29) and 5.1% (95% CI times 2.85-9.17) times respectively. The presence of Killip class II-IV ACF increased the risk of CIN and DM by afactor of 2.2.
Conclusion:
CIN was diagnosed in 7.2% of the patients with myocardial infarction and elevated ST segment; it is associated with the history of DM, CRD, pronounced Killip class II-IV ACF and decreased LVEF DM and clinically manifest ACF were independent predictors of CIN in patients with myocardial infarction and elevated ST segment.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Myocarditis III: Medical Management
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure I: Introduction

